GVK Bio ties up with Endo Pharma

Our Bureau Hyderabad | Updated on January 28, 2013 Published on January 28, 2013

GVK Biosciences has entered into a collaboration agreement with the US-based Endo Pharmaceuticals for discovering novel small molecules targeting a protein.

Under this agreement GVK Bio will use its discovery expertise to deliver a clinical candidate and Endo will develop and commercialise the product arising out of this collaboration.

The Hyderabad-based company recently launched a new initiative called Early Discovery Assets. The early stage asset portfolio is focussed around pain and inflammation. It is about building a set of project assets for potential early stage partnerships.

  Manni Kantipudi, CEO of the company said, "The partnership with Endo is a continuation to build  discovery pipeline through external collaborations."

  [email protected]



Published on January 28, 2013
This article is closed for comments.
Please Email the Editor